Pith. sign in

REVIEW 4 major objections 5 minor 14 references

Enhanced Large Language Models for Effective Screening of Depression and Anxiety

T0 review · 4 major / 5 minor · reviewed 2026-08-10 · deepseek-v4-flash

Challenge this review Re-run · record.json Download PDF Read on arXiv ↗ Review JSON

Pith's one-line read A fine-tuned LLM trained on synthetic clinical interviews outperforms GPT-4 in screening for depression and anxiety.

desk verdict A well-built synthetic-data pipeline and system that beats baselines on its own test set, but the screening claim is only as strong as the synthetic-to-real transfer, which the paper does not establish. read the letter →

arxiv 2501.08769 v2 pith:G2T3XCFF submitted 2025-01-15 cs.CL

June M. Liu , Mengxia Gao , Sahand Sabour , Zhuang Chen , Minlie Huang , Tatia M.C. Lee This is my paper · ORCID
classification cs.CL
keywords largelanguagemodelsmentalhealthscreeningdepressionanxietysyntheticclinicalinterviewsexplainableAIinterviewingEmoScan
verification ladder T0 review T1 audit T2 compute T3 formal

The pith

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The reading

This paper tries to solve a data problem in mental-health AI: real clinical interviews are scarce, expensive, and privacy-protected, so training an LLM to screen for depression and anxiety on them is hard. The authors build a four-stage pipeline that converts casebooks, clinical notes, and healthy-control conversations into 1,157 polished psychiatrist–client dialogues (PsyInterview), then fine-tune the Mistral-7B model on those dialogues to create EmoScan. They report that EmoScan outperforms GPT-4, Llama-3, and the base Mistral model in coarse screening (weighted F1 0.7467), produces semantically strong explanations (BERTScore 0.9408), and keeps much of its advantage on an external depression-risk dataset (F1 0.67). The contribution, if correct, is a scalable lower-cost route to specialized clinical screening tools that does not require direct access to patient data.

What carries the argument

The load-bearing mechanism is the four-stage data-generative pipeline and its output, PsyInterview. Stage one gathers case descriptions from casebooks, clinical notes, scientific literature, and healthy-control conversation sources; stage two extracts structured psychiatric information using a standardized evaluation template covering identification, chief complaint, psychiatric, medical, family, and social history; stage three converts the structured information into raw psychiatrist–client dialogues following a psychiatric-interview topic flow; stage four polishes the dialogues by removing personal identifiers and duplicate content. The resulting corpus is the training substrate for EmoScan's two agents, both built on Mistral-7B: a screening agent fine-tuned on conversational history paired with DSM-5 screening outputs and explanations, and an interviewing agent fine-tuned on the dialogues themselves. The pipeline's work is to inject clinical structure into synthetic dialogues so the model can learn symptom patterns and interviewing behavior without access to real patient data.

What would settle it

Record a set of real, de-identified clinical interviews with independently confirmed DSM-5 diagnoses, run EmoScan on transcripts, and compare the resulting screening F1 with the synthetic-test value of 0.7467; a drop toward the zero-shot baseline range (about 0.21–0.38) would falsify the synthetic-data premise.

Watch

Extended reading notes

Core claim

The central claim is that a domain-specific screening agent trained entirely on synthetic interviews can surpass general-purpose LLMs in clinical screening. From the PsyInterview corpus, EmoScan's screening agent achieved a weighted F1 of 0.7467 for distinguishing depressive and anxiety disorders from healthy controls, with higher precision than recall (0.8667 for anxiety, 0.5400 for depression), a cautious profile the authors connect to fewer false positives. For fine-grained classification of specific disorders it reached 0.2567, far above the base model's 0.0467. EmoScan's explanations scored 0.9408 on BERTScore, and the interviewing agent was rated better than Mistral-7B, Llama-3, and GPT-4 on history-taking and interview-closing dimensions by both GPT-4 and human raters. The authors read these results as evidence that scalable synthetic data pipelines can stand in for expensive real clinical interview collection when training mental-health LLMs.

Load-bearing premise

The results stand on the assumption that the LLM-generated dialogues in PsyInterview are faithful stand-ins for real clinical interviews, so EmoScan's high scores on synthetic dialogues will transfer to actual patients.

Editorial extensions

If this is right

  • Synthetic clinical dialogues can substitute for real interview data in training an LLM screener, lowering the cost and privacy barriers to building mental-health AI.
  • A small fine-tuned model can beat much larger general-purpose LLMs on a narrow clinical task, suggesting that domain-specific training data may matter more than raw model scale for screening accuracy.
  • A high-precision screener with an explanation attached to each result could serve as a triage aid for clinicians, flagging likely emotional disorders while limiting unnecessary follow-up for healthy individuals.
  • The interviewing agent could automate the initial information-gathering phase of assessment, though the paper validates its interviewing skill only against simulated clients rather than real patients.

Reading between the lines

Editorial extensions of the paper, not claims the author makes directly.

  • The same four-stage pipeline could plausibly be repurposed for other diagnostic categories, languages, or cultural settings, since its structure is not specific to depression and anxiety, but the paper does not test those extensions.
  • The external validation set D4 is itself a role-played corpus, so the gap between synthetic training data and real clinical speech remains open; a study with de-identified real patient interviews would be the decisive next test.
  • The cautious high-precision design may under-refer some true cases, and the paper does not specify which clinical settings would rather minimize false negatives than false positives.
Share X Bluesky LinkedIn Reddit HN

Signed reviews

No signed human review yet.

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, and a circularity audit.

Referee Report

4 major / 5 minor

Summary. The paper introduces a four-stage LLM-based generative pipeline that converts case descriptions, casebooks, and clinical notes into 1,157 synthetic psychiatrist-client dialogues (PsyInterview), and uses them to train EmoScan, a Mistral-7B-based system with a screening agent and an interviewing agent. The screening agent is evaluated on a held-out portion of PsyInterview for coarse and fine-grained disorder classification (weighted F1 of 0.7467 and 0.2567, respectively), explanation quality via BERTScore, ROUGE, and BLEU, and generalizability on the Chinese D4 dataset (F1 of 0.67). The interviewing agent is compared against GPT-4, Llama 3, and Mistral-7B using a GPT-4 patient simulator and both GPT-4 and human ratings. The paper concludes that EmoScan outperforms the baselines and GPT-4 in screening, explanation, and interviewing.

Significance. If the synthetic dialogues faithfully represent real clinical interviews, the data-generative pipeline is a valuable contribution: it addresses privacy and cost barriers and could enable scalable training of mental-health LLMs. The strengths of the manuscript include the explicit pipeline design, the creation of a sizable multi-class synthetic corpus, an external out-of-domain check (D4), expert quality ratings of dialogue naturalness, and the use of human raters for interviewing evaluation. The central limitation is that the screening evaluation is self-referential, because both training and test data originate from the same generation pipeline, and the external check is not real clinical data. Consequently, the work's significance is conditional: it demonstrates in-distribution screening and interviewing skills, but it does not yet establish clinical screening ability in real patient populations.

major comments (4)
  1. [Methods: Data Generative Pipeline; Results: Generalizability] The headline screening result (Table 1, F1 = 0.7467) is obtained on PsyInterview, a synthetic test set generated by the same four-stage pipeline that created the training data. The only external validation is D4, a Chinese crowd-worker role-play corpus translated with the Youdao API and scored on a binary depression-risk label; it is compared only with Mistral-7B and no significance test is reported. The expert quality check in Methods: Data Quality-check rates naturalness and alignment on 50 training-set dialogues but never compares generated dialogues against real clinical transcripts, so it does not establish that PsyInterview is distributionally faithful to real clinical interviews. The F1 of 0.7467 therefore cannot currently support the abstract's real-world screening claim; the authors should either validate on real patient interviews or explicitly reframe the result as in-distribution performance and add evidence against generator-specific artifacts.
  2. [Methods: Evaluation, Research Question 1] Statistical significance is established with only three runs per model and unpaired two-sample t-tests (Methods, RQ1), yet Table 1 reports no standard deviations, confidence intervals, or per-run values. With n = 3, the t-test is highly sensitive to a single run, and the observed superiority of EmoScan over GPT-4 (0.7467 vs. 0.5900 in the few-shot condition) could stem from run-to-run variance. Report all three per-run scores, provide bootstrap or permutation confidence intervals, and account for the multiple comparisons across the 12 baseline conditions.
  3. [Results: Table 1; Discussion, Limitations] The fine-grained F1 of 0.2567 (Table 1) is far below a level that would support the abstract's claim that EmoScan distinguishes fine-grained disorders. The authors acknowledge the small per-disorder sample size in the Discussion, but the manuscript still presents the 0.0467-to-0.2567 improvement as evidence of efficacy. Without per-disorder precision and recall, per-disorder sample sizes, and confidence intervals, the fine-grained screening component of the central claim is not established. These numbers should be reported and the claims qualified proportionately.
  4. [Results: Table 2] The explanation-quality claim rests almost entirely on BERTScore (0.9408), while BLEU is 0.0660 and ROUGE-1 is 0.3951. BERTScore is known to reward semantic paraphrase and can be high even when n-gram overlap is low; moreover, the reference explanations are generated by the same pipeline, so high similarity may partly reflect template reuse. No human evaluation of explanation correctness or clinical usefulness is reported. The 'superior explanations' claim should be supported by human judgments or by an analysis that controls for template overlap.
minor comments (5)
  1. [Methods: Data Quality-check] The 50-case expert check is drawn from the training set and uses an arbitrary 'above 50% of the maximum' acceptance threshold; the manuscript does not report inter-rater reliability (e.g., Cohen's kappa) for the three raters.
  2. [Methods: Evaluation, RQ1] The D4 generalizability comparison is performed on machine-translated text via the Youdao API; the footnote states that translation checking was conducted, but no details or metrics are provided, so the reader cannot assess translation quality and its effect on the reported F1.
  3. [Methods: Evaluation, RQ2] The interviewing evaluation lets GPT-4 act as both the simulated patient and the judge; although human raters on 90 pairs provide a useful check, the chi-square tests show association rather than agreement, and the paper should report a kappa-style agreement metric or at least per-dimension agreement rates.
  4. [References] The text cites 'Cheng et al., 2023' for PESConv and 'Konnopka & König, 2022' for the economic burden, but the reference list contains Cheng et al. (2022) and Konnopka & König (2020); the mismatched years and the missing PESConv entry should be corrected.
  5. [Appendix availability] Fine-tuning hyperparameters (Appendix 4), prompts (Appendices 2 and 5), and source lists (Appendix 3) are referenced but not included in the manuscript; for reproducibility, these should be made available as supplementary material, along with a data-release statement for PsyInterview.

Circularity Check

0 steps flagged · score 0.0 of 10

No significant circularity: the headline results are empirical evaluations on a held-out split of the synthetic corpus plus an external D4 check, not derivations that reduce to their own inputs.

full rationale

The paper's central claims are empirical and are not obtained by fitting a parameter and then renaming it as a prediction. EmoScan is fine-tuned on a training split of PsyInterview and evaluated on a held-out test split of the same synthetic corpus, which is a standard in-distribution evaluation rather than a construction that forces the reported F1 scores. The external D4 dataset (Results: Generalizability) provides an independent, out-of-domain comparison, and although it is translated, binary, and crowd-simulated, it is not generated by the paper's own pipeline and therefore breaks any self-referential loop. The explanation-quality scores are measured against ground-truth explanations produced by the same generative pipeline, which raises an external-validity concern about synthetic ground truth, but it is not a definitional or mathematical reduction of the kind required to establish circularity. Self-citations to PESConv and ESConv supply healthy-control case material, but these are data sources, not uniqueness theorems or fitted parameters, so they are not load-bearing in a circular way. No equation or parameter in the paper is defined in terms of the quantity it is claimed to predict, and no fitted value is relabeled as a prediction. Concerns about whether synthetic dialogues faithfully represent real clinical interviews are generalizability and validity risks, not circularity, and under the review rules those concerns do not increase the circularity score.

Assumptions & free parameters 2 free parameters · 4 assumptions · 0 invented entities

The central results depend on assumptions about the fidelity of synthetic dialogues, the validity of DSM-5-derived labels, and the reliability of GPT-4 as both patient simulator and judge. No new theoretical entities are introduced. The model's learned weights and the data quality threshold are the main fitted or ad hoc components.

free parameters (2)
  • Fine-tuning hyperparameters
    Training details are in Appendix 4, not included in the preprint; these affect the reported F1 but are not specified in the main text.
  • Data quality threshold = 2.5/5 (50% of maximum scale)
    The threshold for deeming interview quality acceptable was chosen by the authors; a low bar for a 5-point scale.
assumptions (4)
  • domain assumption LLM-generated synthetic dialogues are clinically faithful and information-complete.
    The training and evaluation data are produced by an LLM pipeline; if the generated interviews omit or distort key clinical information, the screening model will not work on real patients. See Methods: Data Generative Pipeline.
  • domain assumption DSM-5 criteria applied to case descriptions yield correct ground-truth labels.
    The screening labels are derived from the research team's application of DSM-5 criteria to casebook material, without independent clinician diagnosis for the full dataset. See Methods: Data Source.
  • domain assumption GPT-4 acting as a patient simulator and as a judge is a valid proxy for real patients and expert raters.
    The interviewing evaluation uses GPT-4 as the simulated client and as the primary rater; human agreement is assessed only by chi-square association, not by inter-rater reliability coefficients. See Methods: Evaluation RQ2.
  • domain assumption Machine translation of the D4 dataset preserves diagnostic content.
    The external validation relies on translated D4 dialogues; the paper notes translation checking but gives no details or quantitative check of diagnostic equivalence. See Methods: Evaluation RQ1.

how reviews work

0 comments
Cite this review

Pith. "Pith review of Enhanced Large Language Models for Effective Screening of Depression and Anxiety." pith.science (2026). https://pith.science/paper/G2T3XCFF

@misc{pith2026250108769,
  author       = {Pith},
  title        = {Pith review of: Enhanced Large Language Models for Effective Screening of Depression and Anxiety},
  year         = {2026},
  howpublished = {\url{https://pith.science/paper/G2T3XCFF}},
  note         = {Machine review of arXiv:2501.08769}
}
read the original abstract

Depressive and anxiety disorders are widespread, necessitating timely identification and management. Recent advances in Large Language Models (LLMs) offer potential solutions, yet high costs and ethical concerns about training data remain challenges. This paper introduces a pipeline for synthesizing clinical interviews, resulting in 1,157 interactive dialogues (PsyInterview), and presents EmoScan, an LLM-based emotional disorder screening system. EmoScan distinguishes between coarse (e.g., anxiety or depressive disorders) and fine disorders (e.g., major depressive disorders) and conducts high-quality interviews. Evaluations showed that EmoScan exceeded the performance of base models and other LLMs like GPT-4 in screening emotional disorders (F1-score=0.7467). It also delivers superior explanations (BERTScore=0.9408) and demonstrates robust generalizability (F1-score of 0.67 on an external dataset). Furthermore, EmoScan outperforms baselines in interviewing skills, as validated by automated ratings and human evaluations. This work highlights the importance of scalable data-generative pipelines for developing effective mental health LLM tools.

Discussion (0). Continue with ORCID to comment.

Reference graph

Works this paper leans on

14 extracted references · 12 canonical work pages

  1. [1]

    Liu a,b +, Mengxia Gao a,b +, Sahand Sabour c, Zhuang Chen c, Minlie Huang c #, Tatia M.C

    Enhanced Large Language Models for Effective Screening of Depression and Anxiety June M. Liu a,b +, Mengxia Gao a,b +, Sahand Sabour c, Zhuang Chen c, Minlie Huang c #, Tatia M.C. Lee a,b # a State Key Laboratory of Brain and Cognitive Sciences, The University of Hong Kong, Hong Kong, China. b Laboratory of Neuropsychology and Human Neuroscience, The Univ...

    work page 2019

  2. [2]

    The third step involves converting the extracted data into a raw conversation following a topic flow based on Morrison's (2016) guidebook for psychiatric interviews. Briefly, the psychiatrist will first ask the client’s identification and complaints then collect the medical and psychiatric histories, family history, and finally personal and social history...

    work page 2016

  3. [3]

    2 The Interview Generative Pipeline

    Fig. 2 The Interview Generative Pipeline. a. Collect case descriptions from clinical casebooks, clinical notes, scientific literatures, and other related sources. b. Extract information from the case description following a screening template. c. Generate raw interviews from the extracted information. The conversations should follow an interviewing flow. ...

    work page 2023

  4. [4]

    The remaining 744 healthy control cases were sourced from the PESConv dataset (Cheng et al., 2023). The PESConv dataset was adapted from the ESConv dataset (Liu et al., 2021), which was created by recruiting crowd-workers and instructing them to engage in conversations while acting as help-seekers and supporters, with the goal of producing more natural di...

    work page 2023

  5. [5]

    The experts were asked to rate each item on a 5-point Likert scale (1 = very misaligned / not natural at all / etc., 5 = very aligned / very natural / etc.)

    logicality and compliance of explanations. The experts were asked to rate each item on a 5-point Likert scale (1 = very misaligned / not natural at all / etc., 5 = very aligned / very natural / etc.). To further assess the reliability of our data, we adopted an interview skill assessment developed by Morrison (2016). Since the original assessment was desi...

    work page 2016

  6. [7]

    We compared EmoScan with recent widely used LLMs, OpenAI’s GPT-4 (gpt-4-0613) (OpenAI, 2023), Llama 3 (Meta-Llama-3-70B), and Mistral-7B (Jiang et al., 2023)

    Evaluation Baselines. We compared EmoScan with recent widely used LLMs, OpenAI’s GPT-4 (gpt-4-0613) (OpenAI, 2023), Llama 3 (Meta-Llama-3-70B), and Mistral-7B (Jiang et al., 2023). These three LLMs served as baselines in screening/explainability and interviewing evaluation. Research Question 1: Does the screening agent have the ability to do screening and...

    work page 2023

  7. [8]

    This dataset was developed to screen for depression in simulated conversations between two crowdsource workers

    To test the generalizability of EmoScan, we compared our system with the base model on an external out-of-domain dataset, D4 (Yao et al., 2022). This dataset was developed to screen for depression in simulated conversations between two crowdsource workers. Since this dataset was originally in Chinese, we first translated the dataset to English using the Y...

    work page 2022

  8. [9]

    During this process, we instructed GPT-4 to act as a client, responding to the psychiatrist's questions, while providing it with the relevant patient information

    to interact with all four LLMs (i.e., EmoScan, GPT-4, Llama 3, Mistral-7B). During this process, we instructed GPT-4 to act as a client, responding to the psychiatrist's questions, while providing it with the relevant patient information. Simultaneously, we assigned one of the four LLMs to act as the psychiatrist, responsible for asking questions. The int...

    work page 2024

Show all 14 references
  1. [10]

    Model BERTScore BLEU 2-gram ROUGE-1 ROUGE-2 ROUGE-L EmoScan 0.9408 0.0660 0.3951 0.1132 0.2086 Mistral-7B (zero-shot) 0.6897 0.0252 0.2204 0.0539 0.1214 Mistral-7B (few-shot) 0.6110 0.0103 0.1686 0.0341 0.1041 Mistral-7B (CoT) 0.7259 0.0227 0.2258 0.0535 0.1330 Mistral-7B (few...

    2024

  2. [12]

    Papineni, K., Roukos, S., Ward, T., & Zhu, W

    Gpt-4 technical report. Papineni, K., Roukos, S., Ward, T., & Zhu, W. J. (2002). Bleu: a method for automatic evaluation of machine translation. In Proceedings of the 40th annual meeting of the Association for Computational Linguistics (pp. 311-318). Prendergast, K. (2018). Ps...

    2002 arXiv

  3. [13]

    (2023, December)

    Tao, Y., Yang, M., Shen, H., Yang, Z., Weng, Z., & Hu, B. (2023, December). Classifying anxiety and depression through LLMs virtual interactions: A case study with ChatGPT. In 2023 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) (pp. 2259-2264). IEEE. Tu...

    2024 arXiv

  4. [2022]

    While the data quality of D4 was good, the associated costs of human role-playing were relatively high

    employed as a validation dataset in our study was created by recruiting individuals to role-play patients or doctors. While the data quality of D4 was good, the associated costs of human role-playing were relatively high. Other notable studies explored emotional disorders usin...

    2020 arXiv

  5. [2023]

    and clinical tasks (Cong et al., 2024; Longwell et al., 2024). The screening agent will provide a result with an explanation that describes why the client gets the result Psychiatrist(Total)Client(Total)TestTrainTotalCategory--1291,0281,157# Dialogues--1,74314,03715,780# Utter...

    2024

  6. [2024]

    108-126)

    (pp. 108-126). Watson, D., O'Hara, M. W., & Stuart, S. (2008). Hierarchical structures of affect and psychopathology and their implications for the classification of emotional disorders. Depression and Anxiety, 25(4), 282-288. Wei, J., Wang, X., Schuurmans, D., Bosma, M., Xia,...

    2008 arXiv

Pith tools

Reviewed August 10, 2026 · model on record in the stance chip above.